Trial Profile
Stem-cell mobilization by addition of plerixafor to granulocyte–colony-stimulating factor in patients with hematologic malignancies
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Dec 2015
Price :
$35
*
At a glance
- Drugs Plerixafor (Primary) ; Granulocyte colony-stimulating factors
- Indications Stem cell mobilisation
- Focus Therapeutic Use
- 17 Dec 2015 New trial record